Corsair Gaming Valuation
Is CRSR * undervalued compared to its fair value, analyst forecasts and its price relative to the market?
Valuation Score
5/6Valuation Score 5/6
Below Fair Value
Significantly Below Fair Value
Price-To-Sales vs Peers
Price-To-Sales vs Industry
Price-To-Sales vs Fair Ratio
Analyst Forecast
Share Price vs Fair Value
What is the Fair Price of CRSR * when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.
Below Fair Value: CRSR * (MX$184.74) is trading below our estimate of fair value (MX$258.98)
Significantly Below Fair Value: CRSR * is trading below fair value by more than 20%.
Key Valuation Metric
Which metric is best to use when looking at relative valuation for CRSR *?
Other financial metrics that can be useful for relative valuation.
What is CRSR *'s n/a Ratio? | |
---|---|
n/a | 0x |
n/a | n/a |
Market Cap | US$1.17b |
Key Statistics | |
---|---|
Enterprise Value/Revenue | 0.9x |
Enterprise Value/EBITDA | 21x |
PEG Ratio | 5.9x |
Price to Sales Ratio vs Peers
How does CRSR *'s PS Ratio compare to its peers?
Company | Forward PS | Estimated Growth | Market Cap |
---|---|---|---|
Peer Average | 3.1x | ||
2498 HTC | 8.2x | 42.0% | NT$36.1b |
2451 Transcend Information | 3.8x | n/a | NT$40.3b |
DBD Diebold Nixdorf | 0.3x | 2.0% | US$1.2b |
000727 TPV Technology | 0.2x | n/a | CN¥11.3b |
CRSR * Corsair Gaming | 0.8x | 8.5% | Mex$1.2b |
Price-To-Sales vs Peers: CRSR * is good value based on its Price-To-Sales Ratio (0.8x) compared to the peer average (3.1x).
Price to Earnings Ratio vs Industry
How does CRSR *'s PE Ratio compare vs other companies in the Global Tech Industry?
Price-To-Sales vs Industry: CRSR * is good value based on its Price-To-Sales Ratio (0.8x) compared to the Global Tech industry average (1.3x).
Price to Sales Ratio vs Fair Ratio
What is CRSR *'s PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.
Fair Ratio | |
---|---|
Current PS Ratio | 0.8x |
Fair PS Ratio | n/a |
Price-To-Sales vs Fair Ratio: Insufficient data to calculate CRSR *'s Price-To-Sales Fair Ratio for valuation analysis.
Analyst Price Targets
What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?
Date | Share Price | Average 1Y Price Target | Dispersion | High | Low | 1Y Actual price | Analysts |
---|---|---|---|---|---|---|---|
Current | n/a | Mex$272.92 0% | 11.4% | Mex$309.80 | Mex$223.74 | n/a | 7 |
Apr ’25 | Mex$199.00 | Mex$271.05 +36.2% | 11.4% | Mex$307.68 | Mex$222.22 | n/a | 7 |
Mar ’25 | Mex$210.00 | Mex$271.05 +29.1% | 11.4% | Mex$307.68 | Mex$222.22 | n/a | 7 |
Feb ’25 | Mex$226.00 | Mex$308.34 +36.4% | 14.5% | Mex$368.51 | Mex$245.67 | n/a | 7 |
Jan ’25 | Mex$236.59 | Mex$308.34 +30.3% | 14.5% | Mex$368.51 | Mex$245.67 | n/a | 7 |
Dec ’24 | Mex$215.00 | Mex$308.34 +43.4% | 14.5% | Mex$368.51 | Mex$245.67 | n/a | 7 |
Nov ’24 | n/a | Mex$337.63 0% | 8.5% | Mex$359.65 | Mex$274.02 | n/a | 7 |
Oct ’24 | n/a | Mex$337.63 0% | 8.5% | Mex$359.65 | Mex$274.02 | n/a | 7 |
Sep ’24 | Mex$247.00 | Mex$328.03 +32.8% | 10.3% | Mex$357.85 | Mex$272.64 | n/a | 8 |
Aug ’24 | Mex$300.00 | Mex$313.96 +4.7% | 10.9% | Mex$351.63 | Mex$251.17 | n/a | 8 |
Jul ’24 | Mex$300.00 | Mex$322.06 +7.4% | 10.3% | Mex$369.32 | Mex$263.80 | n/a | 8 |
Jun ’24 | Mex$339.07 | Mex$322.06 -5.0% | 10.3% | Mex$369.32 | Mex$263.80 | n/a | 8 |
May ’24 | n/a | Mex$318.94 0% | 8.8% | Mex$360.64 | Mex$270.48 | n/a | 8 |
Apr ’24 | Mex$320.00 | Mex$323.84 +1.2% | 8.0% | Mex$354.49 | Mex$279.86 | Mex$199.00 | 7 |
Mar ’24 | n/a | Mex$323.84 0% | 8.0% | Mex$354.49 | Mex$279.86 | Mex$210.00 | 7 |
Feb ’24 | Mex$284.00 | Mex$300.60 +5.8% | 4.0% | Mex$316.56 | Mex$279.32 | Mex$226.00 | 7 |
Jan ’24 | n/a | Mex$312.27 0% | 3.1% | Mex$331.79 | Mex$292.76 | Mex$236.59 | 8 |
Dec ’23 | Mex$320.00 | Mex$312.27 -2.4% | 3.1% | Mex$331.79 | Mex$292.76 | Mex$215.00 | 8 |
Nov ’23 | Mex$260.00 | Mex$352.65 +35.6% | 7.8% | Mex$397.35 | Mex$317.88 | n/a | 8 |
Oct ’23 | n/a | Mex$367.17 0% | 6.8% | Mex$407.97 | Mex$326.38 | n/a | 8 |
Sep ’23 | n/a | Mex$360.48 0% | 13.1% | Mex$448.90 | Mex$265.26 | Mex$247.00 | 9 |
Aug ’23 | Mex$275.00 | Mex$408.59 +48.6% | 13.9% | Mex$451.95 | Mex$267.06 | Mex$300.00 | 9 |
Jul ’23 | Mex$260.00 | Mex$425.08 +63.5% | 15.1% | Mex$563.79 | Mex$302.03 | Mex$300.00 | 9 |
Jun ’23 | Mex$300.00 | Mex$425.08 +41.7% | 15.1% | Mex$563.79 | Mex$302.03 | Mex$339.07 | 9 |
May ’23 | Mex$316.00 | Mex$535.57 +69.5% | 11.3% | Mex$627.83 | Mex$445.56 | n/a | 9 |
Apr ’23 | Mex$435.00 | Mex$585.16 +34.5% | 11.2% | Mex$737.71 | Mex$512.30 | Mex$320.00 | 9 |
Analyst Forecast: Target price is more than 20% higher than the current share price and analysts are within a statistically confident range of agreement.